科源制药(301281.SZ)终止增发收购相关事项

Core Viewpoint - The company has decided to terminate its plan to issue shares for the acquisition of a 99.42% stake in Shandong Hongjitang Pharmaceutical Group Co., Ltd. and to withdraw related application documents [1] Group 1 - The company initially intended to issue shares to 38 counterparties, including Linuo Investment Holding Group Co., Ltd. and Linuo Group Co., Ltd. [1] - The company planned to raise supporting funds by issuing shares to no more than 35 qualified specific objects [1] - The board of directors has approved the resolution to terminate the share issuance for asset acquisition and related transactions [1]